Cargando…
High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
Isolated α,β-dehydromonacolin S (C5) from soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178 was recently shown to exhibit an inhibitory effect against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity in vitro. In this study, we investigated the effects of C5 on lipid-lowering,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073358/ https://www.ncbi.nlm.nih.gov/pubmed/33920678 http://dx.doi.org/10.3390/ph14040375 |
_version_ | 1783684111854993408 |
---|---|
author | Kaewmalee, Jutatip Ontawong, Atcharaporn Duangjai, Acharaporn Tansakul, Chittreeya Rukachaisirikul, Vatcharin Muanprasat, Chatchai Srimaroeng, Chutima |
author_facet | Kaewmalee, Jutatip Ontawong, Atcharaporn Duangjai, Acharaporn Tansakul, Chittreeya Rukachaisirikul, Vatcharin Muanprasat, Chatchai Srimaroeng, Chutima |
author_sort | Kaewmalee, Jutatip |
collection | PubMed |
description | Isolated α,β-dehydromonacolin S (C5) from soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178 was recently shown to exhibit an inhibitory effect against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity in vitro. In this study, we investigated the effects of C5 on lipid-lowering, hepatic steatosis, and hepatic gluconeogenesis in vivo. The control rats received a daily dose of either vehicle or C5 at 10 mg/kg, while the high-fat diet-induced obese (HFD) rats were administered vehicle; 1, 3, or 10 mg/kg C5; or 10 mg/kg lovastatin (LO) for 6 weeks. C5 significantly improved dyslipidemia and diminished liver enzymes, HMGR activity, insulin resistance, and hepatic steatosis, comparable to LO without any hepatotoxicity and nephrotoxicity in HFD rats. A higher efficacy of C5 in lipid-lowering activity and anti-hepatic steatosis was associated with a significant decrease in genes involved in lipid metabolism including sterol regulatory element binding protein (SREBP) 1c, SREBP2, liver X receptor alpha (LXRα), and peroxisome proliferator-activated receptor (PPAR) gamma (PPARγ) together with an increase in the PPAR alpha (PPARα). Correspondingly, C5 was able to down-regulate the lipid transporters cluster of differentiation 36 (CD36) and Niemann-Pick C1 Like 1 (NPC1L1), increase the antioxidant superoxide dismutase gene expression, and decrease the proinflammatory cytokines, tumor necrosis factor alpha (TNFα) and interleukin 1 beta (IL-1β). Impairment of hepatic gluconeogenesis and insulin resistance in HFD rats was restored by C5 through down-regulation of the gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), and the activation of AMP-dependent kinase serine (AMPK) and serine/threonine protein kinase B (Akt). Collectively, this novel C5 may be a therapeutic option for treating dyslipidemia, hepatic steatosis, and reducing potential risk for diabetes mellitus. |
format | Online Article Text |
id | pubmed-8073358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80733582021-04-27 High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats Kaewmalee, Jutatip Ontawong, Atcharaporn Duangjai, Acharaporn Tansakul, Chittreeya Rukachaisirikul, Vatcharin Muanprasat, Chatchai Srimaroeng, Chutima Pharmaceuticals (Basel) Article Isolated α,β-dehydromonacolin S (C5) from soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178 was recently shown to exhibit an inhibitory effect against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity in vitro. In this study, we investigated the effects of C5 on lipid-lowering, hepatic steatosis, and hepatic gluconeogenesis in vivo. The control rats received a daily dose of either vehicle or C5 at 10 mg/kg, while the high-fat diet-induced obese (HFD) rats were administered vehicle; 1, 3, or 10 mg/kg C5; or 10 mg/kg lovastatin (LO) for 6 weeks. C5 significantly improved dyslipidemia and diminished liver enzymes, HMGR activity, insulin resistance, and hepatic steatosis, comparable to LO without any hepatotoxicity and nephrotoxicity in HFD rats. A higher efficacy of C5 in lipid-lowering activity and anti-hepatic steatosis was associated with a significant decrease in genes involved in lipid metabolism including sterol regulatory element binding protein (SREBP) 1c, SREBP2, liver X receptor alpha (LXRα), and peroxisome proliferator-activated receptor (PPAR) gamma (PPARγ) together with an increase in the PPAR alpha (PPARα). Correspondingly, C5 was able to down-regulate the lipid transporters cluster of differentiation 36 (CD36) and Niemann-Pick C1 Like 1 (NPC1L1), increase the antioxidant superoxide dismutase gene expression, and decrease the proinflammatory cytokines, tumor necrosis factor alpha (TNFα) and interleukin 1 beta (IL-1β). Impairment of hepatic gluconeogenesis and insulin resistance in HFD rats was restored by C5 through down-regulation of the gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), and the activation of AMP-dependent kinase serine (AMPK) and serine/threonine protein kinase B (Akt). Collectively, this novel C5 may be a therapeutic option for treating dyslipidemia, hepatic steatosis, and reducing potential risk for diabetes mellitus. MDPI 2021-04-17 /pmc/articles/PMC8073358/ /pubmed/33920678 http://dx.doi.org/10.3390/ph14040375 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kaewmalee, Jutatip Ontawong, Atcharaporn Duangjai, Acharaporn Tansakul, Chittreeya Rukachaisirikul, Vatcharin Muanprasat, Chatchai Srimaroeng, Chutima High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats |
title | High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats |
title_full | High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats |
title_fullStr | High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats |
title_full_unstemmed | High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats |
title_short | High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats |
title_sort | high-efficacy α,β-dehydromonacolin s improves hepatic steatosis and suppresses gluconeogenesis pathway in high-fat diet-induced obese rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073358/ https://www.ncbi.nlm.nih.gov/pubmed/33920678 http://dx.doi.org/10.3390/ph14040375 |
work_keys_str_mv | AT kaewmaleejutatip highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats AT ontawongatcharaporn highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats AT duangjaiacharaporn highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats AT tansakulchittreeya highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats AT rukachaisirikulvatcharin highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats AT muanprasatchatchai highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats AT srimaroengchutima highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats |